"Antibody fragments: Prolonging circulation half-life special issue-antibody research"
written by Annabelle Patricia Herrington-Symes, Monika Farys, Hanieh Khalili, Steve Brocchini,
published by Advances in Bioscience and Biotechnology, Vol.4 No.5, 2013
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Combining the best of two worlds: Highly flexible chimeric antigen receptor adaptor molecules (CAR-adaptors) for the recruitment of chimeric antigen receptor T cells
[2] Next Generation Biopharmaceuticals: Product Development
New Bioprocessing Strategies: Development and Manufacturing of Recombinant Antibodies and Proteins, 2018
[3] Docetaxel loaded immunonanoparticles delivery in EGFR overexpressed breast carcinoma cells
Journal of Drug Delivery Science and Technology, 2018
[4] Enhanced expression of soluble antibody fragments by low-temperature and overdosing with a nitrogen source
Enzyme and Microbial Technology, 2018
[5] Tuning the Hydrolytic Stability of Next Generation Maleimide Cross-Linkers Enables Access to Albumin-Antibody Fragment Conjugates and tri-scFvs
Bioconjugate Chemistry, 2018
[6] Overview of Antibody Drug Delivery
Pharmaceutics, 2018
[7] Sélection de fragments d'anticorps dirigés contre les microcystines pour la mise au point de tests d'immunodétection
Thèse, 2018
[8] Antibody fragments as potential biopharmaceuticals for cancer therapy: success and limitations
[9] Affimer-based impedimetric biosensors: the new analytical platform for biorecognition applications
[10] Synthesis of Fc peptides and glycopeptides to be used as internal standards for absolute quantitation of glycoforms of two human IgG subclasses by MALDI-MS …
[11] Self aggregation of IgG fragments from different perspectives
[12] Antibody Half‐Life
Biosimilars of Monoclonal Antibodies: A Practical Guide to Manufacturing, Preclinical, and Clinical Development, 2017
[13] Fc Engineering for developing therapeutic bispecific antibodies and novel scaffolds
Frontiers in immunology, 2017
[14] Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy
Scientific Reports, 2017
[15] Development of a novel nano-sized anti-VEGFA nanobody with enhanced physicochemical and pharmacokinetic properties
South African Journal of Clinical Nutrition, 2017
[16] Ligand-Targeted Drug Delivery
Chemical Reviews, 2017
[17] Microbial platform technology for recombinant antibody fragment production: A review
Geocarto International, 2016
[18] Approach for Half-Life Extension of Small Antibody Fragments That Does Not Affect Tissue Uptake
Bioconjugate Chemistry, 2016
[19] Co-stimulation Blockade Plus T-Cell Depletion in Transplant Patients: Towards a Steroid-and Calcineurin Inhibitor-Free Future?
Drugs, 2016
[20] Antibody Half‐Life: Engineering for Optimal Performance
Biosimilars of Monoclonal Antibodies: A Practical Guide to Manufacturing, Preclinical, and Clinical Development, 2016
[21] Evaluation of pharmacokinetics and pharmacodynamics and clinical efficacy of certolizumab pegol for Crohn's disease
Expert opinion on drug metabolism & toxicology, 2015
[22] Antibody Fragments and Their Purification by Protein L Affinity Chromatography
Antibodies, 2015
[23] Encapsidated Atom-Transfer Radical Polymerization in Qβ Virus-like Nanoparticles
ACS nano, 2014